AMN Healthcare Services, Inc.
NYSE:AMNMedical - Care Facilities
-$1.29 today
- Market cap
- $1.45B
- Beta
- 0.44
- P/E (TTM)
- -37.3
- EPS (TTM)
- -$0.83
Volume 0.55M
Average 1.02M
AMN Account Payables
Amounts the company owes suppliers for goods and services received.
AMN Healthcare Services, Inc.NYSE: AMN
Account Payables · Q1 FY2026 · quarter ended Mar 2026
Account payables rises 81.4% from a year ago
Account payables stood at $197.39M at the end of Q1 FY2026, up 81.4% from a year earlier and up 132.4% from the prior quarter. Over 3 fiscal years it compounded at -38.9% a year.
Context
- Account payables amounted to 7.6% of total assets at the end of Q1 FY2026, up 3.0 pp from a year earlier.
- Account payables increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +81.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 84.95M USD
- Year-over-year change
- -15.8%
- 4-year CAGR
- -29.2%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 84.95M | -15.8% |
| FY2024 | 2024-12-31 | 100.92M | -43.0% |
| FY2023 | 2023-12-31 | 177.11M | -52.6% |
| FY2022 | 2022-12-31 | 373.32M | +10.1% |
| FY2021 | 2021-12-31 | 339.01M | — |
Account Payables vs competitors
How AMN compares with its peers on the latest reported figures
- AMN's Mar 2026 account payables of $197.39M is the highest of the 11 companies compared; the peer median is $9.17M.
- Its year-over-year change of +81.4% is the 2nd highest of 11, against a peer median of +25.2%.
- Account payables amounts to 7.6% of total assets for AMN, versus a peer median of 1.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $197.39M | +81.4% | -38.9% | 7.6% | |
| Mar 2026 | $63.01M | +9.0% | +1.5% | 3.4% | |
| Mar 2026 | $50.37M | +97.4% | +27.0% | 5.3% | |
| Mar 2026 | $32.6M | +16.0% | +1.4% | 4.8% | |
| Mar 2026 | $16.31M | +44.8% | +0.4% | 1.6% | |
| Mar 2026 | $10.88M | +26.7% | +47.3% | 2.0% | |
| Mar 2026 | $7.46M | +80.3% | +11.8% | 3.9% | |
| Jun 2026 | $7.13M | -38.2% | — | 1.2% | |
| Dec 2025 | $5.65M | -21.4% | +49.5% | 1.7% | |
| Mar 2026 | $5.09M | +60.1% | +2.2% | 1.0% | |
| Mar 2026 | $2.82M | +23.7% | -9.0% | 1.0% | |
| Peer median (excluding AMN) | $9.17M | +25.2% | +2.2% | 1.9% | |
Competitors are the stored peer set for AMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 180.93M | 64.52M | 32.94M | 10.65M | 33.97M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.03B | 953.25M | 746.54M | 519.98M | 439.11M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 66.83M | 57.16M | 40.32M | 41.78M | 51.43M |
| Total Current Assets | 1.35B | 1.09B | 841.69M | 594.92M | 545.38M |
| Property, Plant & Equipment (Net) | 154.89M | 165.54M | 225.93M | 218.39M | 136.36M |
| Goodwill | 892.34M | 935.36M | 1.11B | 897.46M | 755.81M |
| Intangible Assets | 514.46M | 476.83M | 474.13M | 381.36M | 283.53M |
| Long-term Investments | 0 | 0 | 0 | 0 | 45.61M |
| Tax Assets | 0 | 0 | 0 | 25.83M | 44.88M |
| Other Non-current Assets | 221.15M | 216.97M | 271.1M | 297.78M | 282.55M |
| Total Non-current Assets | 1.78B | 1.79B | 2.08B | 1.82B | 1.55B |
| Total Assets | 3.13B | 2.89B | 2.92B | 2.42B | 2.09B |
| Account Payables | 339.01M | 373.32M | 177.11M | 100.92M | 84.95M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 21.16M | 0 | 0 | 0 | 0 |
| Deferred Revenue | 157.05M | 33.29M | 20.01M | 66.36M | 106.83M |
| Other Current Liabilities | 250.48M | 251.95M | 223.39M | 237.53M | 256.35M |
| Total Current Liabilities | 969.39M | 857.93M | 656.12M | 545.79M | 577.61M |
| Long-term Debt | 842.32M | 843.51M | 1.3B | 1.06B | 767.05M |
| Deferred Tax Liabilities | 47.81M | 22.71M | 23.35M | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 96.99M | 111.21M | 71.38M | 71.73M | 77.19M |
| Total Non-current Liabilities | 1B | 986.78M | 1.44B | 1.16B | 874.39M |
| Total Liabilities | 1.97B | 1.84B | 2.09B | 1.71B | 1.45B |
| Common Stock | 498K | 501K | 504K | 507K | 511K |
| Retained Earnings | 796.95M | 1.24B | 1.45B | 1.3B | 1.21B |
| Accumulated OCI | (295K) | (939K) | (423K) | (11K) | 298K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.16B | 1.04B | 831.26M | 706.62M | 642.11M |
| Total Debt | 867.07M | 860.96M | 1.35B | 1.1B | 803.2M |
| Net Debt | 686.14M | 796.43M | 1.32B | 1.09B | 769.23M |
AMN Healthcare Services, Inc.
NYSE:AMN
Intrinsic Alpha fair value
Locked
Current Price
$37.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.